Annotation
Legislation and drug trials
| The first 150 words of the full text of this article appear below. |
| |
Article |
|---|
Drugs used to treat children are often not licensed for use in this age group. Examples of licensed medicines used outside the conditions of the licence (`off label' usage) include the oral administration of a vitamin K injection preparation, and cisapride, which is commonly prescribed for infants, but is not licensed for children under 2 years of age. The main reason many drugs are not licensed for use in children is that drug trials, and in particular pharmacokinetic studies, are difficult to undertake in the young child. This leads to a reluctance on the part of pharmaceutical companies to become involved in such trials.
In Ireland, the Control of Clinical Trials and Drugs Act
19901 has led to problems in paediatric research. In the
United Kingdom, clinical trials in children are conducted with the
consent of a local or hospital ethics committee. Before 1987, this was also the case in the Republic
This article has been cited by other articles:
-
Imrie, C., Rowland, M., Bourke, B., Drumm, B.
(2001). Is Helicobacter pylori Infection in Childhood a Risk Factor for Gastric Cancer?. Pediatrics
107: 373-380
[Abstract] [Full Text] -
FINN, A.
(1997). Legislation and drug trials. Arch. Dis. Child.
77: 276b-276
[Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.



